FDAs Gesture for Firm Manufacturing Drug for Cushings Syndrome
...manufacturers Corcept Therapeutics has received orphan drug status for its corlux
from the Food and Drug Administration (F.D.A.).
Cushing's Syndrome ...ng the FDA decision, Corcept said it was yet to finalise its strategies for corlux
but would start going about marketing the drug soon.